Skip to content

LV PHARMA

Active Risk: not assessed
Private limited companyfounded 2020active for 5 yearsDe Loecht(WIE) 1, 2222 Heist-op-den-Berg, BelgiumKBO/BCE: BE 0758.798.435

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
10-08
NBB filing Annual accounts 2025 filedNBB
abbreviated format · 10 days late
2025
31-12
Financial Highest result from 2021 to 2025net €93,711 ▲56.7%
The operating result of €180,251 and the net result of €93,711 are both a record.
31-12
Financial Equity above €200,000equity €227,464 ▲70.1%
With a profit in every financial year since 2021, equity grows to €227,464.
25-07
NBB filing Annual accounts 2024 filedPDF
abbreviated format · 6 days before the deadline
2024
31-12
Financial Equity above €100,000equity €133,753 ▲80.9%
With a profit in every financial year since 2021, equity grows to €133,753.
26-08
NBB filing Annual accounts 2023 filedPDF
abbreviated format · 26 days late
2023
31-12
Financial Weakest financial yearnet €2,098 ▼94.1%
The net result drops to €2,098, the lowest from 2021 to 2025. It recovers the following year.
28-08
NBB filing Annual accounts 2022 filedPDF
micro format · 28 days late
02-06
Gazette deed General meeting · DeclarationPDF
Kind of shares · Amendment of the articles
2022
19-08
NBB filing Annual accounts 2021 filedPDF
micro format · 19 days late
2020
30-11
Gazette deed IncorporationPDF
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

On 26 November 2020, LV PHARMA was incorporated as a private limited company.1 Total assets went from €55,086 in 2021 to €1.4m in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2021 and 2025

Next steps